New therapies in development and simpler methods of diagnosis offer hope for dementia patients of all ages, says Professor Nick Fox of UCL and UCLH.
Scientists at a new UCL centre will use tools such as machine learning to analyse intensive care data from two London hospitals to find clues that will improve the care of critically ill adults and babies.
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
UCLH and UCL researchers are working with Microsoft to see if chest imaging data can identify better who should shield in potential future COVID-19 outbreaks.
Researchers have highlighted the importance of routinely screening healthcare staff for the SARS-CoV-2 virus after finding a high proportion of front-facing staff had the virus during the peak of the pandemic.
Could dogs offer quick and effective diagnosis of Covid-19?
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
Stroke patients who should be calling an ambulance appear to have stayed at home during the Covid-19 outbreak, according to an analysis by researchers who urged anyone who thinks they may be having a stroke.
A UCLH patient has received T-cell therapy for advanced lung cancer in a world first.
UCLH teams were crucial to a large, international research study published in The Lancet over the weekend that is set to change guidelines around the treatment of gastrointestinal (GI) bleeding.
In this Q&A ENT surgeon at UCLH Prof Martin Birchall tells us about the technology his team are testing to improve communication while wearing personal protective equipment (PPE).
A new study at UCLH will look into the impact of COVID-19 infection on patients undergoing chemotherapy for treatment of Acute Myeloid Leukaemia (AML), a type of cancer that affects the blood cells. This study will involve 34 NHS hospitals and the lead for UCLH will be Dr Jenny O’Nions.
The steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients, according to initial results from a national priority trial in which UCLH is involved.